Peptide Therapeutics Market by Technology (Hybrid Phase, Liquid Phase, Solid Phase), API Type (CMO, In-house), Drug Class, Application, End User - Global Forecast 2023-2030

Peptide Therapeutics Market by Technology (Hybrid Phase, Liquid Phase, Solid Phase), API Type (CMO, In-house), Drug Class, Application, End User - Global Forecast 2023-2030

The Peptide Therapeutics Market size was estimated at USD 30.10 billion in 2022 and expected to reach USD 33.40 billion in 2023, at a CAGR 11.03% to reach USD 69.56 billion by 2030.

Peptide therapeutics refers to the use of short chains of amino acids for the treatment or prevention of various diseases and medical conditions. These biologically active molecules possess unique properties that make them an efficient option in drug development and pharmaceutical research. The surging prevalence of chronic diseases, including cancer and diabetes, is raising the need for effective treatment options and an improved understanding of protein-protein interactions leading to targeted therapies. Growing investment in research & development activities and a robust clinical pipeline with therapeutic candidates are resulting in the development of novel peptide therapeutics. However, the inherent instability of peptides and the high cost of manufacturing peptides may adversely impact the development of peptide therapeutics. Moreover, recent developments in drug delivery systems are expected to expand the potential applications for peptides.

Regional Insights

The peptide therapeutics market is evolving in the Americas owing to the presence of well-established pharmaceutical industries, an increase in research activities, and a growing number of approved peptide drugs. Patent activity in this region is notable, with several prominent pharmaceutical companies headquartered in the area. In recent years, investments in innovative peptide formulations have also increased, indicating a strong market potential for new therapeutic approaches. The peptide therapeutics market is developing in the EMEA region due to the regulatory framework supporting innovation within biotechnology and funding research projects related to peptide therapeutics. The rising prevalence of chronic disease, improving healthcare infrastructure, and growing awareness regarding peptide therapeutics are encouraging the growth of the peptide therapeutics market in the APAC region. Besides, ongoing advancements and the development of more efficient, scalable, and cost-effective synthetic strategies for producing peptides are anticipated to encourage the development and adoption of peptide therapeutics globally.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Peptide Therapeutics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Peptide Therapeutics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Peptide Therapeutics Market, highlighting leading vendors and their innovative profiles. These include AmbioPharm Inc., Amgen Inc., Arcturus Therapeutics Holdings Inc., AstraZeneca PLC, Bachem AG, Bristol Myers Squibb Company, Cidara Therapeutics, Inc., Corden Pharma International GmbH, Dynavax Technologies Corporation, Eli Lilly and Company, F. Hoffmann-La Roche Ltd, GlaxoSmithKline PLC, Ipsen, Merck & Co., Inc., Novartis AG, Novo Nordisk A/S, Otsuka Pharmaceutical Co., Ltd., Pfizer Inc., Piramal Group (Piramal Pharma Solution), PolyPeptide Group, Relief Therapeutics Holding AG, Sanofi S.A., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., and Zealand Pharma A/S.

Market Segmentation & Coverage

This research report categorizes the Peptide Therapeutics Market to forecast the revenues and analyze trends in each of the following sub-markets:

Technology

Hybrid Phase

Liquid Phase

Solid Phase

API Type

CMO

In-house

Drug Class

Calcitonins

Glucagon & Analogs

Insulins

Luteinizing Hormone-Releasing Hormone

Somatostatins

Vasopressin

Application

Anti-infective

Cancer

Cardio Vascular Disease Respiratory

Central Nervous System

Dermatology

Gastrointestinal

Metabolic

Renal

End User

Hospitals

Pharmaceutical Industries

Research Laboratories

Region

Americas

Argentina

Brazil

Canada

Mexico

United States

California

Florida

Illinois

New York

Ohio

Pennsylvania

Texas

Asia-Pacific

Australia

China

India

Indonesia

Japan

Malaysia

Philippines

Singapore

South Korea

Taiwan

Thailand

Vietnam

Europe, Middle East & Africa

Denmark

Egypt

Finland

France

Germany

Israel

Italy

Netherlands

Nigeria

Norway

Poland

Qatar

Russia

Saudi Arabia

South Africa

Spain

Sweden

Switzerland

Turkey

United Arab Emirates

United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Peptide Therapeutics Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Peptide Therapeutics Market?
3. What are the technology trends and regulatory frameworks in the Peptide Therapeutics Market?
4. What is the market share of the leading vendors in the Peptide Therapeutics Market?
5. Which modes and strategic moves are suitable for entering the Peptide Therapeutics Market?

Please Note: PDF & Excel + Online Access - 1 Year